| dc.contributor.author |
Nikiteas, N |
en |
| dc.contributor.author |
Tzanakis, N |
en |
| dc.contributor.author |
Theodoropoulos, G |
en |
| dc.contributor.author |
Atsaves, V |
en |
| dc.contributor.author |
Christoni, Z |
en |
| dc.contributor.author |
Karakitsos, P |
en |
| dc.contributor.author |
Lazaris, A |
en |
| dc.contributor.author |
Papachristodoulou, A |
en |
| dc.contributor.author |
Klonaris, C |
en |
| dc.contributor.author |
Gazouli, M |
en |
| dc.date.accessioned |
2014-06-06T06:47:34Z |
|
| dc.date.available |
2014-06-06T06:47:34Z |
|
| dc.date.issued |
2007 |
en |
| dc.identifier.uri |
http://dx.doi.org/10.1007/s10120-006-0401-8 |
en |
| dc.identifier.uri |
http://62.217.125.90/xmlui/handle/123456789/3687 |
|
| dc.subject |
Gene Polymorphism |
en |
| dc.subject |
Immunohistochemistry |
en |
| dc.subject |
Lymph Node Metastasis |
en |
| dc.subject |
Overall Survival |
en |
| dc.subject |
Patient Survival |
en |
| dc.subject |
Statistical Significance |
en |
| dc.subject |
Vascular Endothelial Growth Factor |
en |
| dc.subject |
Gastric Carcinoma |
en |
| dc.subject |
Gastric Cancer |
en |
| dc.subject |
kaplan meier |
en |
| dc.subject |
Restriction Fragment Length Polymorphism Analysis |
en |
| dc.title |
Vascular endothelial growth factor and endoglin (CD105) in gastric cancer |
en |
| heal.type |
journalArticle |
en |
| heal.identifier.primary |
10.1007/s10120-006-0401-8 |
en |
| heal.publicationDate |
2007 |
en |
| heal.abstract |
Background Vascular endothelial growth factor (VEGF) overexpression has been associated with advanced stage and poor survival in several cancers. Additionally, CD-105 (endoglin) was proposed as a marker of neovascularization in solid malignancies. The aim of the present study was to (1) evaluate the VEGF and CD-105 expression in gastric carcinoma, (2) determine the role of VEGF gene sequence variations in VEGF |
en |
| heal.journalName |
Gastric Cancer |
en |
| dc.identifier.doi |
10.1007/s10120-006-0401-8 |
en |